dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorYazbek, Priscila Baptistella
dc.creatorTrindade, Ariane Biolcati
dc.creatorChin, Chung Man
dc.creatorDos Santos, Jean Leandro
dc.date2015-12-07T15:34:39Z
dc.date2016-10-25T21:23:25Z
dc.date2015-12-07T15:34:39Z
dc.date2016-10-25T21:23:25Z
dc.date2015
dc.date.accessioned2017-04-06T09:29:59Z
dc.date.available2017-04-06T09:29:59Z
dc.identifierDigestive Diseases And Sciences, v. 60, n. 10, p. 2901-2912, 2015.
dc.identifier1573-2568
dc.identifierhttp://hdl.handle.net/11449/131387
dc.identifierhttp://acervodigital.unesp.br/handle/11449/131387
dc.identifier10.1007/s10620-015-3712-y
dc.identifier25999247
dc.identifierhttp://dx.doi.org/10.1007/s10620-015-3712-y
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/941927
dc.descriptionHelicobacter pylori (H. pylori) is one of the leading causes of gastric diseases such as chronic gastritis, peptic ulcer, and gastric adenocarcinoma. The current treatment of H. pylori infection with antibiotics and proton pump inhibitors has several limitations, including poor adherence and intrinsic patient-related factors, drug resistance, and the absence of adequate treatments. This review summarizes the current therapeutic approaches to eradicating H. pylori, the difficulties associated with its treatment, and several new perspectives aimed at improving existing treatment strategies.
dc.languageeng
dc.publisherDigestive Diseases And Sciences
dc.relationDigestive Diseases And Sciences
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectGastric diseases
dc.subjectH. pylori eradication
dc.subjectH. pylori resistance
dc.subjectHelicobacter pylori
dc.subjectTreatment
dc.titleChallenges to the treatment and new perspectives for the eradication of helicobacter pylori
dc.typeOtro


Este ítem pertenece a la siguiente institución